Steve Swallow
#80,268
Most Influential Person Now
American jazz bassist and composer
Steve Swallow's AcademicInfluence.com Rankings
Steve Swallowcommunications Degrees
Communications
#3853
World Rank
#5400
Historical Rank
#1687
USA Rank
Linguistics
#1718
World Rank
#2164
Historical Rank
#443
USA Rank

Download Badge
Communications
Why Is Steve Swallow Influential?
(Suggest an Edit or Addition)According to Wikipedia, Steve Swallow is an American jazz bassist and composer, known for his collaborations with Jimmy Giuffre, Gary Burton, and Carla Bley. He was one of the first jazz double bassists to switch entirely to electric bass guitar.
Steve Swallow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Fluorine in medicinal chemistry. (2008) (3788)
- Fluorine in medicinal chemistry. (2008) (558)
- In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. (2012) (196)
- Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479. (2007) (86)
- The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine. (2009) (69)
- Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules. (2011) (50)
- The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. (2009) (41)
- Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point. (2017) (40)
- Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase. (2008) (37)
- Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). (2016) (37)
- 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase. (2009) (35)
- Enantioselective allylic acyloxylation catalysed by copper–oxazoline† complexes (1998) (32)
- Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. (2009) (28)
- Stereoselective Synthesis of cis-2,5-Disubstituted Tetrahydrofurans Using Oxabicyclo[3.2.1]heptanone Platforms. Building Blocks for Natural Product Synthesis (1994) (26)
- Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase. (2008) (26)
- Discovery of a potent and selective oral inhibitor of ERK1/2 (AZD0364) that is efficacious in both monotherapy and combination therapy in models of non-small cell lung cancer (NSCLC). (2019) (24)
- Electrophilic amination of carbanions by N-carboxamido oxaziridines (2000) (22)
- Enantioselective synthesis of homoallylic alcohols using(E)-but-2-enyl-trichlorosilane and chiral diamines (1997) (22)
- Stereoselective synthesis of the cyclic ether core of (+)-laurenyne (2004) (21)
- Pharmacological and electrophysiological characterization of AZSMO‐23, an activator of the hERG K+ channel (2015) (20)
- Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimzation. (2015) (17)
- A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines (2018) (16)
- Novel cyclizations involving vinyl sulfones: Stereoselective construction of perhydroazulenes and trans-hydrindanes. (1993) (14)
- Enantioselective propargylic oxidation (1998) (12)
- Asymmetric electrophilic amination of enolates by a chiral N-alkoxycarbonyloxaziridine (2001) (11)
- A concise synthesis of homochiral trans-perhydroazulenes and trans-hydrindanes (2001) (9)
- Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability (2007) (9)
- The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. (2012) (8)
- CONVERGENT SYNTHESIS OF THE PUTATIVE BIOGENETIC PRECURSOR OF MYCAPEROXIDE B AND A NORSESTERTERPENE TRIENE ISOLATED FROM AN AUSTRALIAN SPONGE (1999) (8)
- SINGLET OXYGEN CYCLOADDITION TO DIENES : A BIOMIMETIC APPROACH TO MARINE ENDOPEROXIDES? (1999) (6)
- Cycloaddition Approaches to Oxygen Heterocycles Applied to Natural Product Synthesis (1999) (6)
- Fluorine-Containing Pharmaceuticals (2012) (6)
- Short convergent syntheses of 1,11-epithio and 1,11-epoxy steroids (1990) (5)
- Novel and versatile synthesis of disubstituted 1,2-dihydro-1,2,4-triazol-3-ones. (2013) (5)
- The impact of radiochemistry in drug projects: The use of C-14 labeled in the AZD8529, AZD7325 and AZD6280 projects. (2020) (3)
- Short Convergent Synthesis of 1,11-Epithio and 1,11-Epoxy Steroids. (1991) (1)
- Convergent Synthesis of the Putative Biogenetic Precursor of Mycaperoxide B and a Norsesterterpene Triene Isolated from an Australian Sponge. (2010) (1)
- Stereoselective Synthesis of the Cyclic Ether Core of (+)-Laurenyne. (2005) (1)
- Electrophilic Amination of Carbanions by N‐Carboxamido Oxaziridines. (2000) (1)
- Abstract 1647: Discovery of AZD0364, a potent and selective oral inhibitor of ERK1/2 that is efficacious in both monotherapy and combination therapy in models of NSCLC (2018) (1)
- Novel and Versatile Synthesis of Disubstituted 1,2‐Dihydro‐1,2,4‐triazol‐3‐ones. (2014) (0)
- Novel Cyclizations Involving Vinyl Sulfones: Stereoselective Construction of Perhydroazulenes and trans‐Hydrindans. (1994) (0)
- A Concise Synthesis of Homochiral trans-Perhydroazulenes and trans-Hydrindanes. (2001) (0)
- Graphical contents list (2012) (0)
- Enantioselective Synthesis of Homoallylic Alcohols Using (E)‐But‐2‐ enyl‐trichlorosilane and Chiral Diamines. (2010) (0)
- Stereoselective Synthesis of cis-2,5-Disubstituted Tetrahydrofurans Using Oxabicyclo(3.2.1)heptanone Platforms. Building Blocks for Natural Product Synthesis. (1995) (0)
- Inhibitors of the non-nucleoside reverse transcriptase inhibitors (2004) (0)
- Predictive secondary pharmacology: Concepts and application to drug discovery (2011) (0)
- Pharmacological and electrophysiological characterisation of hERG activator AZSMO-23 1 Running title : Characterisation of hERG activator AZSMO-23 (2015) (0)
- Asymmetric Electrophilic Amination of Enolates by a Chiral N‐Alkoxycarbonyloxaziridine. (2001) (0)
- Human Erk2 with an Erk1/2 inhibitor (2017) (0)
- Inhibitors and non-nucleoside reverse transcriptase I for treating diseases mediated by HIV (2004) (0)
This paper list is powered by the following services:
Other Resources About Steve Swallow
What Schools Are Affiliated With Steve Swallow?
Steve Swallow is affiliated with the following schools: